Streetbeat News

Equity Actions

SMCI

Supermicro has announced a proposed public offering of 2,100,700 shares of its common stock. Of these, 2 million shares are being offered by Supermicro itself, while the remaining 100,700 shares are being offered by certain selling stockholders.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 9:22 pm

CRM

Salesforce Inc has filed with the SEC for a mixed shelf offering, although the size of the offering has not been disclosed.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 9:18 pm

LEXX

Lexaria Bioscience Corp has filed with the SEC for the resale of up to 1.6 million shares of common stock by the selling stockholder.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 9:18 pm

ACR

ACRES Commercial Realty has reauthorized an additional $10 million share repurchase program, signaling confidence in the company's value and a commitment to returning value to shareholders.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 9:15 pm

LSCC

Lattice Semiconductor has expanded its stock repurchase program with a new $250 million authorization, effective immediately.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 9:01 pm

PSX

Phillips 66 (PSX) stock is trading higher following confirmation of ongoing discussions with Elliot Investment Management, which recently disclosed a $1 billion stake in PSX and intentions to seek board seats.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 8:10 pm

RNAZ

TransCode Therapeutics, Inc. (RNAZ) has announced a registered direct offering of 5,000,000 shares of common stock at $0.242 per share, aiming to raise approximately $1.2 million. The offering is priced at-the-market under Nasdaq rules, with H.C. Wainwright & Co. as the exclusive placement agent. The expected closing date is around December 4, 2023. The funds raised will support clinical trials for TTX-MC138, their lead therapeutic candidate, and for general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 8:00 pm

YOSH

Yoshiharu Global Co (NASDAQ:YOSH) stock dropped 38% to $5.69 amid volatility following a 1-for-10 reverse stock split to comply with Nasdaq listing rules. The split affected equity awards and warrants, with fractional shares rounded up. Yoshiharu also plans to acquire Las Vegas restaurant assets for $3.6 million, aiming to boost revenue by 80% with four new establishments in early 2024. The company targets managing 13 restaurants by year-end to strengthen its Las Vegas presence and financial growth.

Portfolio Pulse from Henry Khederian

November 30, 2023 | 7:54 pm

XENE

Xenon Pharmaceuticals Inc (NASDAQ: XENE) shares rose by 7.8% after the company announced the pricing of its upsized $300 million public offering at $32.50 per share. The offering includes 8,461,542 common shares and pre-funded warrants, with an additional option for underwriters to purchase up to 1,384,615 common shares. The offering is expected to close around December 4. J.P. Morgan, Jefferies, BofA Securities, Stifel, and RBC Capital Markets are the joint book-running managers.

Portfolio Pulse from Henry Khederian

November 30, 2023 | 7:51 pm

ENSC

Ensysce Biosciences, Inc. has filed a request with the SEC to withdraw its previously filed Registration Statement on Form S-3. The company had initially filed the statement for the resale of shares by selling securityholders, but no shares were sold under this registration. A reverse stock split reduced the number of shares covered, and a subsequent public offering increased the number of shares outstanding. The company repaid in full the convertible note and other amounts owed with cash, making the registration for resale unnecessary. Ensysce is requesting that the fees paid for the filing be credited for future use.

Portfolio Pulse from Benzinga Newsdesk

November 30, 2023 | 7:42 pm